Technology
Health
Biotechnology

Merrimack Pharmaceuticals

$6.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.32%) Today
+$0.06 (0.96%) After Hours

Why Robinhood?

You can buy or sell MACK and other stocks, options, ETFs, and crypto commission-free!

About

Merrimack Pharmaceuticals, Inc. Common Stock, also called Merrimack Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Read More Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Employees
27
Headquarters
Cambridge, Massachusetts
Founded
1993
Market Cap
83.13M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
109.97K
High Today
$6.24
Low Today
$6.18
Open Price
$6.23
Volume
1.62K
52 Week High
$10.53
52 Week Low
$3.34

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Cancer Prevention
Pharmaceutical

News

Yahoo FinanceMay 10

Merrimack Reports First Quarter 2019 Financial Results

CAMBRIDGE, Mass., May 10, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (MACK), an oncology company focused on biomarker-defined cancers, today announced its first quarter 2019 financial results for the period ended March 31, 2019. "We continue to focus our efforts on completing the review of our strategic alternatives through which we are committed to optimizing value for our stockholders, including the preservation of potential contractual milestone payments Merrimack is eligible to receive," said...

44

Earnings

-$1.88
-$1.34
-$0.81
-$0.27
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.78 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.